A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type-Reference-Cited by-同舟云学术

A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type

Published:2018-09 Issue:9 Volume:138 Page:1982-1989
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Beylot-Barry Marie,Mermin Diane,Maillard Aline,Bouabdallah Reda,Bonnet Nathalie,Duval-Modeste Anne-Bénédicte,Mortier Laurent,Ingen-Housz-Oro Saskia,Ram-Wolff Caroline,Barete Stéphane,Dalle Stéphane,Maubec Eve,Quereux Gaelle,Templier Isabelle,Bagot Martine,Grange Florent,Joly Pascal,Vergier Béatrice,Vially Pierre-Julien,Gros Audrey,Pham-Ledard Anne,Frison Eric,Merlio Jean-Philippe

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference54 articles.

1. A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma;Arora;Ther Adv Hematol,2016

2. Lenalidomide for the treatment of B-cell malignancies;Chanan-Khan;J Clin Oncol,2008

3. Revised response criteria for malignant lymphoma;Cheson;J Clin Oncol,2007

4. Mutations of multiple genes cause deregulation of NF-kB in diffuse large B-cell lymphoma;Compagno;Nature,2009

5. A phase 2/3 multicenter, randomized study comparing the efficacy and safety of lenalidomide versus investigator’s choice in relapsed/refractory DLBCL;Czuczman;Clin Cancer Res,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Perspectives for Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type;Chemotherapy;2023-12-08

2. Efficacy and Safety Profile of Lenalidomide vs Lenalidomide + R-CHOP in patients with Diffuse Large B Cell Lymphoma: A Systematic Review;Pakistan Journal of Health Sciences;2023-08-31

3. What is new about primary cutaneous B cell lymphomas;Italian Journal of Dermatology and Venereology;2023-06

4. Cutaneous B‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-05-22

5. Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment;Journal of Investigative Dermatology;2023-02